700 related articles for article (PubMed ID: 35385985)
21. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
22. Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy.
Placke JM; Mertens D; Tasdogan A; Chorti E; Schadendorf D; Ugurel S; Roesch A; Stoffels I; Klode J
J Eur Acad Dermatol Venereol; 2023 May; 37(5):907-913. PubMed ID: 36606548
[TBL] [Abstract][Full Text] [Related]
23. Hypermetabolic Axillary Lymphadenopathy After Shingrix Vaccination for Varicella Zoster Virus.
Eshet Y; Eifer M; Domachevsky L; Tau N
Clin Nucl Med; 2024 Mar; 49(3):e127-e128. PubMed ID: 38271246
[TBL] [Abstract][Full Text] [Related]
24. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
25. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Ah-Thiane L; Ferrer L; Maucherat B; Fleury V; Le Thiec M; Rusu D; Rousseau C
Clin Nucl Med; 2022 Jul; 47(7):575-582. PubMed ID: 35675134
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
[TBL] [Abstract][Full Text] [Related]
27. Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study.
Li Y; Han D; Shen C; Duan X
BMC Cancer; 2023 Oct; 23(1):1028. PubMed ID: 37875818
[TBL] [Abstract][Full Text] [Related]
28. False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.
Nawwar AA; Searle J; Hopkins R; Lyburn ID
Clin Nucl Med; 2021 Dec; 46(12):1004-1005. PubMed ID: 33883486
[TBL] [Abstract][Full Text] [Related]
29. Imaging of COVID-19 Vaccine-Related Axillary Lymphadenopathy: Initial Outcomes Based on US Features of Axillary Lymph Nodes.
Ahn RW; Porembka JH; Mootz AR; Goudreau SH; Dogan BE; Xi Y; Seiler SJ
J Breast Imaging; 2023 Mar; 5(2):135-147. PubMed ID: 38416930
[TBL] [Abstract][Full Text] [Related]
30. Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study.
Zhu Y; Ma Y; Zhai Z; Liu A; Wang Y; Zhang Y; Li H; Zhao M; Han P; Yin L; He N; Wu Y; Sechopoulos I; Ye Z; Caballo M
Eur Radiol; 2024 Apr; 34(4):2576-2589. PubMed ID: 37782338
[TBL] [Abstract][Full Text] [Related]
31. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD
Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992
[TBL] [Abstract][Full Text] [Related]
32. Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on
Seban RD; Richard C; Nascimento-Leite C; Ghidaglia J; Provost C; Gonin J; Tourneau CL; Romano E; Deleval N; Champion L
J Nucl Med; 2022 Aug; 63(8):1231-1238. PubMed ID: 34857663
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
[TBL] [Abstract][Full Text] [Related]
34. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
[TBL] [Abstract][Full Text] [Related]
35. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
[TBL] [Abstract][Full Text] [Related]
36. [
Nogami M; Tsujikawa T; Maeda H; Kosaka N; Takahashi M; Kinoshita N; Mori T; Makino A; Kiyono Y; Murakami T; Goi T; Okazawa H
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296702
[TBL] [Abstract][Full Text] [Related]
37. Preliminary study on the ability of the machine learning models based on
Wang J; Zhou Y; Zhou J; Liu H; Li X
Eur J Radiol; 2024 Jul; 176():111531. PubMed ID: 38820949
[TBL] [Abstract][Full Text] [Related]
38. A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
Song BI
Breast Cancer; 2021 May; 28(3):664-671. PubMed ID: 33454875
[TBL] [Abstract][Full Text] [Related]
39. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG-Avid Lymph Nodes After COVID-19 Vaccination on 18F-FDG PET/CT.
Ulaner GA; Giuliano P
Clin Nucl Med; 2021 May; 46(5):433-434. PubMed ID: 33782318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
